In addition, it was revealed that the tumor microenvironment changes the anti-tumor function of CD8+ T-cells through the induction of the CD39 expression (an immunosuppressive ATP ectonucleotidase) and the reduction of effector markers. This evidence concerns the gene ENTPD1 and neoplasm.